NP
NVO

NorthRock Partners’s Novo Nordisk NVO Stock Holding History

NorthRock Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-200
Closed -$16.2K – 370
2023
Q2 		$16.2K Buy
+200
New +$16.3K ﹤0.01% 311

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

NorthRock Partners's NVO Position: Q2 2026 in Review

NorthRock Partners increased its Novo Nordisk (NVO) stake by 79% in Q2 2026, buying an estimated $238K and bringing the position to 12,559 shares worth $602K. The position accounts for 0.01% of the portfolio, ranked #400.

NorthRock Partners first reported a position in NVO in Q3 2023 and has held it in 8 quarters since. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • NorthRock Partners held 12,559 shares of Novo Nordisk worth $602K as of Q2 2026.
  • NorthRock Partners bought 5,533 Novo Nordisk shares in Q2 2026, an estimated $238K.
  • Novo Nordisk made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #400 holding.
  • NorthRock Partners first reported a position in Novo Nordisk in Q3 2023 and has held it in 8 quarters since.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.